Compound Detail
CHEMBL69129
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL69129 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UJWXPHLWGVGIBB-UHFFFAOYSA-N |
6
Targets
8
Activities
1
Assay Types
0
PK Parameters
9
Publications
0
Known Names
Molecular Properties
386.4
MW (Da)
4.56
ALogP
6
HBA
2
HBD
86.2
PSA (Ų)
0.54
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 8 meas. best 8.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase Lck CHEMBL258 | IC50 | 8.3 | 7.28 | 5.0 | 2 |
| Jurkat CHEMBL397 | IC50 | 7.55 | 6.535 | 28.0 | 2 |
| Angiopoietin-1 receptor CHEMBL4128 | IC50 | 7.23 | 7.23 | 58.3 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 7.07 | 7.07 | 85.0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src CHEMBL267 | IC50 | 7.06 | 7.06 | 88.0 | 1 |
| Protein kinase C (PKC) CHEMBL2093867 | IC50 | 4.48 | 4.48 | 33000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tyrosine-protein kinase Lck | IC50 | = | 5.0 | nM | 8.3 | Inhibition of p56 Lck tyrosine kinase at 1 mM ATP | 11012021 |
| Jurkat | IC50 | = | 28.0 | nM | 7.55 | Inhibition of MLR stimulated IL-2 production in Jurkat cells | 11012021 |
| Angiopoietin-1 receptor | IC50 | = | 58.3 | nM | 7.23 | Inhibition of tie-2 at 5 uM ATP | 11012021 |
| Vascular endothelial growth factor receptor 2 | IC50 | = | 85.0 | nM | 7.07 | Inhibition of Vascular endothelial growth factor receptor 2 at 5 uM ATP | 11012021 |
| Proto-oncogene tyrosine-protein kinase Src | IC50 | = | 88.0 | nM | 7.06 | Inhibition of src at 5 mM ATP | 11012021 |
| Tyrosine-protein kinase Lck | IC50 | = | 544.0 | nM | 6.26 | Inhibition of p56 Lck tyrosine kinase catalytic domain at 1 mM ATP | 11012021 |
| Jurkat | IC50 | = | 3000.0 | nM | 5.52 | Inhibition of PMA stimulated IL-2 production in Jurkat cells | 11012021 |
| Protein kinase C (PKC) | IC50 | = | 33000.0 | nM | 4.48 | Inhibition of PKC | 11012021 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 11012021 | 10.1016/s0960-894x(00)00441-8 | Tyrosine-protein kinase Lck | 4 |
| 11012021 | 10.1016/s0960-894x(00)00441-8 | Jurkat | 3 |
| 11012021 | 10.1016/s0960-894x(00)00441-8 | Proto-oncogene tyrosine-protein kinase Src | 1 |
| 11012021 | 10.1016/s0960-894x(00)00441-8 | Vascular endothelial growth factor receptor 2 | 1 |
| 11012021 | 10.1016/s0960-894x(00)00441-8 | Angiopoietin-1 receptor | 1 |
| 11012021 | 10.1016/s0960-894x(00)00441-8 | Tyrosine-protein kinase ZAP-70 | 1 |
| 11012021 | 10.1016/s0960-894x(00)00441-8 | Epidermal growth factor receptor | 1 |
| 11012021 | 10.1016/s0960-894x(00)00441-8 | Protein kinase C (PKC) | 1 |
| 11012021 | 10.1016/s0960-894x(00)00441-8 | Cyclin-dependent kinase 1/cyclin B | 1 |
Data from ChEMBL 36 via Core Engine